U. Margaretha Wallon

Dr. Wallon is spearheading translational research in oncology, in particular biomarkers to predict nausea in patients who will undergo chemotherapy (MyNauseaRisk) and for prognosis and treatment of triple-negative breast cancers. Her lab also is testing cryoablation as autovaccination for breast cancers.